Skip to main content

Published locations for FDA approves IL-17A antagonist for treating psoriatic arthritis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves IL-17A antagonist for treating psoriatic arthritis

User login

  • Reset your password
  • /content/fda-approves-il-17a-antagonist-treating-psoriatic-arthritis
  • /edermatologynews/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating
  • /familypracticenews/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating
  • /internalmedicinenews/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating
  • /rheumatologynews/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating
  • /rheumatology/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating-psoriatic
  • /internalmedicine/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating
  • /dermatology/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating-psoriatic
  • /familymedicine/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating-psoriatic
  • /rheumatology/psoriatic-arthritis-resource-center/article/153302/psoriatic-arthritis/fda-approves-il
  • /dermatology/psoriasiscollection/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist
  • /psoriatic-arthritis-icymi/article/153302/psoriatic-arthritis/fda-approves-il-17a-antagonist-treating